Cognetivity Neurosciences Company Top Insiders
| CGNSF Stock | USD 0 0 42.86% |
Cognetivity Neurosciences employs about 6 people. The company is managed by 6 executives with a total tenure of roughly 14 years, averaging almost 2.0 years of service per executive, having 1.0 employees per reported executive. Examination of Cognetivity Neurosciences' management performance can provide insight into the company performance.
| BA BA Insider Legal Director |
| Jonathan ElSharkawy Insider Chief Officer |
Cognetivity |
Cognetivity Neurosciences Management Team Effectiveness
The company has return on total asset (ROA) of (2.0431) % which means that it has lost $2.0431 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (6.4283) %, meaning that it generated substantial loss on money invested by shareholders. Cognetivity Neurosciences' management efficiency ratios could be used to measure how well Cognetivity Neurosciences manages its routine affairs as well as how well it operates its assets and liabilities.Cognetivity Neurosciences Workforce Comparison
Cognetivity Neurosciences is number one stock in number of employees category among its peers. The total workforce of Health Information Services industry is currently estimated at about 435. Cognetivity Neurosciences claims roughly 6.0 in number of employees contributing just under 2% to equities under Health Information Services industry.
Cognetivity Neurosciences Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Cognetivity Neurosciences Price Series Summation is a cross summation of Cognetivity Neurosciences price series and its benchmark/peer.
Cognetivity Neurosciences Notable Stakeholders
A Cognetivity Neurosciences stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Cognetivity Neurosciences often face trade-offs trying to please all of them. Cognetivity Neurosciences' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Cognetivity Neurosciences' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| BA BA | Legal Director | Profile | |
| Jonathan ElSharkawy | Chief Officer | Profile | |
| Sina Habibi | CEO CoFounder | Profile | |
| SeyedMahdi KhalighRazavi | CoFounder Officer | Profile | |
| Thomas MBA | CFO, COO | Profile | |
| Christos Kalafatis | Chief Director | Profile |
About Cognetivity Neurosciences Management Performance
The success or failure of an entity such as Cognetivity Neurosciences often depends on how effective the management is. Cognetivity Neurosciences management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Cognetivity management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Cognetivity management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Cognetivity Neurosciences Ltd. operates as a healthcare company. Cognetivity Neurosciences Ltd. was incorporated in 2015 and is headquartered in Vancouver, Canada. Cognetivity Neurosciences operates under Health Information Services classification in the United States and is traded on OTC Exchange.
Cognetivity Neurosciences Workforce Analysis
Traditionally, organizations such as Cognetivity Neurosciences use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Cognetivity Neurosciences within its industry.Cognetivity Neurosciences Manpower Efficiency
Return on Cognetivity Neurosciences Manpower
| Revenue Per Employee | 0.0 | |
| Revenue Per Executive | 0.0 | |
| Net Loss Per Employee | 2.2M | |
| Net Loss Per Executive | 2.2M |
Complementary Tools for Cognetivity Pink Sheet analysis
When running Cognetivity Neurosciences' price analysis, check to measure Cognetivity Neurosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cognetivity Neurosciences is operating at the current time. Most of Cognetivity Neurosciences' value examination focuses on studying past and present price action to predict the probability of Cognetivity Neurosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cognetivity Neurosciences' price. Additionally, you may evaluate how the addition of Cognetivity Neurosciences to your portfolios can decrease your overall portfolio volatility.
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators |